CJC-1295 / Ipamorelin Blend

The CJC-1295 / Ipamorelin Blend combines two of the most extensively studied growth hormone secretagogues in a single 5mg/5mg lyophilized research vial. CJC-1295 (a GHRH analogue) extends the half-life of endogenous GHRH signaling, while Ipamorelin (a selective GHS-R agonist) stimulates pulsatile GH release with high specificity and minimal cortisol or prolactin elevation. Together, they produce a synergistic amplification of GH secretion that has made this combination a key subject of research into growth hormone axis regulation, body composition modulation, lean mass preservation, and metabolic rate studies. Each vial is supplied as a lyophilized powder, third-party HPLC-tested for purity ≥98%, and intended strictly for in vitro and qualified laboratory research use.